Increased risk of dementia among overactive bladder patients treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study

Uro-Oncology

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study

World J Urol.

Jerlström T, Chen R, Liedberg F, Andrén O, Ströck V, Aljabery FAS, Hosseini A, Sherif A, Malmström PU, Ullén A, Gårdmark T, Fall K

doi: 10.1007/s00345-019-02770-2

Overactive Bladder

Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

Health Qual Life Outcomes.

Herschorn S, Staskin D, Tu LM, Fialkov J, Walsh T, Gooch K, Schermer CR

doi: 10.1186/s12955-018-0892-0.

Pregnancy and Childbirth

Adverse childhood experiences are associated with increased risk of miscarriage in a national population-based cohort study in England

Hum Reprod.

Demakakos P, Linara-Demakakou E, Mishra GD

doi: 10.1093/humrep/deaa113.

Overactive Bladder

A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

Int Urogynecol J.

Staskin D, Herschorn S, Fialkov J, Tu LM, Walsh T, Schermer CR

doi: 10.1007/s00192-017-3377-5.

Overactive Bladder

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice

Eur Urol.

Chapple CR, Nazir J, Hakimi Z, Bowditch S, Fatoye F, Guelfucci F, Khemiri A, Siddiqui E, Wagg A

doi: 10.1016/j.eururo.2017.01.037.

Overactive Bladder

Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

Eur Urol.

Gratzke C, van Maanen R, Chapple C, Abrams P, Herschorn S, Robinson D, Ridder A, Stoelzel M, Paireddy A, Yoon SJ, Al-Shukri S, Rechberger T, Mueller ER

doi: 10.1016/j.eururo.

Reproductive Health

Risk of hospitalization for early onset of cardiovascular disease among infertile women: a register-based cohort study

Hum Reprod.

Bungum AB, Glazer CH, Arendt LH, Schmidt L, Pinborg A, Bonde JP, Tøttenborg SS

doi: 10.1093/humrep/dez154.

Pregnancy and Childbirth

Maternal thyroid disorder in pregnancy and risk of cerebral palsy in the child: a population-based cohort study

BMC Pediatr.

Petersen TG, Andersen AN, Uldall P, Paneth N, Feldt-Rasmussen U, Tollånes MC, Strandberg-Larsen K

doi: 10.1186/s12887-018-1152-5.

Overactive Bladder

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial

Patient.

Herdman M, Nazir J, Hakimi Z, Siddiqui E, Huang M, Pavesi M, MacDiarmid S, Drake MJ, Devlin N

doi: 10.1007/s40271-017-0262-8.

Related content

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study

Patient-reported outcomes in patients with overactive bladder treated with mirabegron and tolterodine in a prospective, double-blind, randomized, two-period crossover, multicenter study (PREFER)

Adverse childhood experiences are associated with increased risk of miscarriage in a national population-based cohort study in England

A prospective, double-blind, randomized, two-period crossover, multicenter study to evaluate tolerability and patient preference between mirabegron and tolterodine in patients with overactive bladder (PREFER study)

Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice

Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)

Risk of hospitalization for early onset of cardiovascular disease among infertile women: a register-based cohort study

Maternal thyroid disorder in pregnancy and risk of cerebral palsy in the child: a population-based cohort study

Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial